# Biofil Chemicals & Pharmaceuticals (NSE: BIOFILCHEM) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/BIOFILCHEM · Pivot · prices to 22 Oct 2026

Biofil Chemicals & Pharmaceuticals (NSE: BIOFILCHEM) closed at ₹30.00 on 22 Oct 2026, up 2.15% on the day. With a market capitalisation of ₹49 Cr, it ranks 3083rd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.

At its last close the stock traded at 17.5× trailing earnings, against a return on equity of 3.0% in FY25. Over the past year the share price has fallen 27.3%. Its 52-week range is ₹25.60 (30 Mar 2026) to ₹46.34 (3 Feb 2026); the last close is 35.3% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹8 Cr (−9.3% year on year) and net profit ₹0 Cr (+5.0%), on a standalone basis. Promoters held 46.79% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹30.00 |
| Market cap | ₹49 Cr |
| P/E (trailing) | 17.5 |
| ROE | 3.0% (FY25) |
| ROCE | 4.0% (FY25) |
| Debt to equity | 0.03 |
| 52-week high | ₹46.34 (3 Feb 2026) |
| 52-week low | ₹25.60 (30 Mar 2026) |
| 1-year return | −27.3% |

## Quarterly results (₹ crore, standalone)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹8 Cr | −9.3% | ₹0 Cr | +5.0% | ₹0.13 |
| Q3 FY26 | ₹1 Cr | −93.9% | ₹0 Cr | −50.0% | ₹0.05 |
| Q2 FY26 | ₹14 Cr | +461.8% | ₹0 Cr | +300.0% | ₹0.05 |
| Q1 FY26 | ₹6 Cr | −23.8% | ₹2 Cr | +1,317.6% | ₹1.48 |
| Q4 FY25 | ₹8 Cr | −45.1% | ₹0 Cr | −20.0% | ₹0.12 |
| Q3 FY25 | ₹14 Cr | +182.3% | ₹0 Cr | +77.8% | ₹0.10 |
| Q2 FY25 | ₹2 Cr | −86.1% | ₹0 Cr | −83.3% | ₹0.01 |
| Q1 FY25 | ₹8 Cr | +247.3% | ₹0 Cr | −29.2% | ₹0.10 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹33 Cr | ₹1 Cr |
| FY24 | ₹40 Cr | ₹1 Cr |
| FY23 | ₹30 Cr | ₹1 Cr |
| FY22 | ₹22 Cr | ₹1 Cr |
| FY21 | ₹36 Cr | ₹1 Cr |
| FY20 | ₹30 Cr | ₹1 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 46.79%
- Domestic institutions: 0.08%
- Non-institutions: 53.13%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Vivimed Labs](https://app.pivotnow.in/stock/VIVIMEDLAB) | ₹6.21 | ₹51 Cr | — | — |
| [Shree Pacetroni](https://app.pivotnow.in/stock/SHREEPAC) | — | ₹50 Cr | — | — |
| [Shanmuga Hospit](https://app.pivotnow.in/stock/SHANMUGA) | — | ₹48 Cr | — | — |
| [Mangalam Drugs And Organics](https://app.pivotnow.in/stock/MANGALAM) | ₹29.66 | ₹47 Cr | — | — |
| [Amkay Products](https://app.pivotnow.in/stock/AMKAY) | — | ₹46 Cr | — | — |
| [Shelter Pharma](https://app.pivotnow.in/stock/SHELTER) | — | ₹46 Cr | — | — |

## Questions and answers

### What is the share price of Biofil Chemicals & Pharmaceuticals today?

Biofil Chemicals & Pharmaceuticals (NSE: BIOFILCHEM) last closed at ₹30.00 on 22 Oct 2026. Its 52-week high is ₹46.34 and its 52-week low is ₹25.60.

### What is the market cap of Biofil Chemicals & Pharmaceuticals?

Biofil Chemicals & Pharmaceuticals' market capitalisation is ₹49 Cr (₹49 Cr) at the 22 Oct 2026 close, ranking 3083rd among the NSE companies Pivot tracks.

### What is the P/E ratio of Biofil Chemicals & Pharmaceuticals?

Biofil Chemicals & Pharmaceuticals trades at a trailing P/E of 17.5.

### What is the ROE and ROCE of Biofil Chemicals & Pharmaceuticals?

Return on equity was 3.0% in FY25 and return on capital employed was 4.0% in FY25 (standalone figures).

### Is Biofil Chemicals & Pharmaceuticals a debt-free company?

Biofil Chemicals & Pharmaceuticals is close to debt-free: its debt-to-equity ratio was 0.03 in FY25.

### What were Biofil Chemicals & Pharmaceuticals' latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), Biofil Chemicals & Pharmaceuticals reported revenue of ₹8 Cr, −9.3% year on year, and net profit of ₹0 Cr, +5.0% year on year.

### How has Biofil Chemicals & Pharmaceuticals stock performed over the last year?

Biofil Chemicals & Pharmaceuticals' share price has fallen 27.3% over the past year, −10.5% over three months and −8.0% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of Biofil Chemicals & Pharmaceuticals?

As of 30 Jun 2026: promoters 46.79%, domestic institutions 0.08%, non-institutions 53.13%.

### Who are Biofil Chemicals & Pharmaceuticals' competitors?

The listed Pharma & Healthcare companies closest to Biofil Chemicals & Pharmaceuticals by market cap are Vivimed Labs, Shree Pacetroni, Shanmuga Hospit, Mangalam Drugs And Organics, Amkay Products and Shelter Pharma.

### Is Biofil Chemicals & Pharmaceuticals a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Biofil Chemicals & Pharmaceuticals' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on BIOFILCHEM against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.